The Corporate Prosecution Reform Act establishes a new Office of Corporate Enforcement within the Department of Justice to oversee agreements with companies accused of federal crimes. It restricts the use of deferred and non-prosecution agreements by banning them for offenses involving loss of life, serious injury, or specific crimes like terrorism and human trafficking, while requiring courts to ensure these deals adequately compensate victims and prevent future misconduct. To increase transparency, the bill mandates that the Attorney General publish the full text of all such agreements on a public website and submit annual reports to Congress detailing their terms and compliance. Additionally, the legislation creates standardized guidance for prosecutors to ensure consistent penalties for similar corporate offenses and updates federal crime categories to include cyber and financial crimes.
The Next GEN Act of 2026 modifies the Drug Price Negotiation Program to include a specific category of medications called engineered cyclic peptides. This change extends the time before these drugs can be negotiated for lower prices from seven years to eleven years. The bill defines these peptides as synthetic, amino acid-based drugs that are self-administered and created using genetic library screening methods. By adjusting the timeline, the legislation directly affects pharmaceutical companies and the government agencies responsible for setting drug prices under the program.
This bill establishes a five-year pilot program to help homeowners convert their property basements into safe, rentable living units. The Department of Housing and Urban Development will insure up to 150,000 mortgages specifically designed to fund these necessary improvements. To ensure safety, the program requires that converted spaces meet all local building codes and will prioritize projects in areas prone to natural hazards after consulting with federal emergency management agencies. At the end of the five-year period, the Department must submit a report to Congress detailing the program's results and offering recommendations on whether to continue or change it.
The Radiation Health Research Act directs the National Institutes of Health to create a program specifically studying the health effects of nuclear radiation on women. This initiative requires long-term monitoring of participants, including pregnant women and young girls, for at least ten years while ensuring their privacy is protected. The program must involve collaboration with various federal agencies and align with current scientific evidence. Additionally, the Director of NIH is required to submit annual reports to Congress detailing research findings, identifying knowledge gaps, and proposing strategies to minimize adverse health effects.
The Extinction Prevention Act of 2026 establishes four separate conservation funds to provide financial assistance for protecting threatened and endangered species in specific regions. The bill creates funds for butterflies in North America, plants in the Pacific Islands, freshwater mussels in the United States, and desert fish in the Southwest, with each fund managed by the Secretary of the Interior. Eligible applicants, such as state agencies, nonprofits, and research institutions, can apply for competitive grants to support habitat protection, research, and management plans, while federal agencies are restricted to partnering roles rather than leading projects. Each fund is authorized to receive $5 million annually from 2027 through 2032, and the Secretary must submit annual reports to Congress detailing project outcomes and the status of the species.
This Senate resolution expresses the non-binding opinion that federal laws regarding medication abortion should rely on scientific evidence rather than political influence. It specifically calls for the FDA to maintain its approval of mifepristone, a drug proven safe and effective over 25 years, and to allow patients to access it through telemedicine or mail-order pharmacies. The measure highlights that current restrictions disproportionately harm marginalized communities, including people of color, low-income individuals, and those in rural areas. By stating these points, the resolution aims to encourage policymakers to ensure equitable and transparent access to abortion care based on medical consensus.
This resolution formally acknowledges the Black Women Best framework, a policy blueprint designed to address historical economic disparities faced by Black women in the United States. It highlights specific strategies such as implementing guaranteed income, expanding tax credits, improving healthcare access, removing police from schools, and prioritizing restorative justice. The measure serves as a non-binding statement of support rather than a law that directly changes federal programs or mandates new actions. By recognizing this framework, the House encourages policymakers to use it as a guide for creating more equitable legislation that centers the lived experiences of Black women.
This resolution formally acknowledges the significant behavioral health challenges, such as anxiety and caregiver burnout, faced by individuals and families dealing with rare diseases. It calls on federal agencies to prioritize mental health support within rare disease initiatives and encourages the expansion of standardized peer support programs. The bill also urges improvements in workforce training, cultural competency, and insurance reimbursement to ensure equitable access to care. Ultimately, it serves as a statement of recognition rather than a law that creates new funding or mandates specific regulations.
This non-binding resolution expresses the sense of the House of Representatives that it is U.S. policy to officially recognize the ongoing displacement of Palestinians known as the Nakba and to support their right of return. The measure calls for the commemoration of this event, the denunciation of current displacement efforts, and increased funding for United Nations social services for Palestinian refugees. Additionally, it urges the U.S. government to stop providing weapons and diplomatic support to Israel for actions that contribute to the displacement of Palestinians.
This resolution declares stroke a national health crisis and calls for immediate, coordinated federal action to improve care. It highlights that while a specific treatment called mechanical thrombectomy is highly effective, very few eligible patients currently receive it due to delays in emergency response and hospital routing. The bill urges the creation of standardized training for emergency medical services to better recognize strokes and directs ambulances to transport patients directly to hospitals equipped for this treatment. Additionally, it encourages public education campaigns to help people recognize stroke symptoms and calls for greater transparency regarding which hospitals can perform the necessary procedures.
This resolution expresses the House of Representatives' preference for a trade policy that prioritizes American workers, consumers, independent farmers, small businesses, and the environment over corporate interests. It calls for trade agreements to include binding labor and environmental standards, fair wage guarantees, and strict rules of origin to prevent companies from moving jobs overseas. The measure also supports strengthening domestic manufacturing requirements, maintaining tariffs against unfair trade practices, and ensuring that public procurement favors American-made goods. Additionally, it urges the inclusion of provisions to protect data privacy, regulate artificial intelligence, and ensure affordable access to medicine while preventing monopolies.
This non-binding resolution expresses the House of Representatives' view that the FDA should regulate mifepristone, a medication used for abortion, based on scientific evidence rather than political pressure. It highlights over 25 years of data showing the drug is safe and effective when prescribed via telemedicine or dispensed by mail and pharmacy. The bill advocates for policies that ensure equitable access to this care, particularly for marginalized communities facing barriers due to state-level restrictions. By citing numerous studies and medical organizations, the resolution calls for transparent, science-based decisions to maintain current access methods.
